Park Sunghoon, Yoon Joon-Kee, Chung Nam-Su, Kim Sang Hyun, Hwang Jinwoo, Lee Hyun Young, Kwack Kyu-Sung
1 Department of Radiology, Ajou University School of Medicine , Suwon , South Korea.
2 Musculoskeletal Imaging Laboratory, Ajou University Medical Center , Suwon , South Korea.
Br J Radiol. 2018 Jun;91(1086):20170889. doi: 10.1259/bjr.20170889. Epub 2018 Mar 20.
To investigate the relationship between intravoxel incoherent motion (IVIM) diffusion-weighted MRI (DW MRI) parameters and F-fluodeoxyglucose (FDG) (PET/CT) metabolic parameters in patients with vertebral bone metastases.
19 patients with vertebral bone metastases were retrospectively included in this institutional review board-approved study. All patients underwent IVIM DW-MRI and F-FDG PET/CT before treatment. The IVIM parameters [molecular diffusion coefficient (D), perfusion fraction (f), and perfusion-related D (D*)] and apparent diffusion coefficient were acquired using 11 b-values (0, 10, 15, 20, 25, 50, 80, 120, 200, 300, and 800 s mm). Maximum and mean standardized uptake values (SUVmax and SUVmean, respectively), metabolic tumor volume, and total lesion glycolysis derived from F-FDG PET/CT were calculated using thresholds of 3.0 SUV. The associations among parameters were evaluated by Spearman's correlation analysis.
A total of 19 patients and 41 regions of interest were included in this study. The IVIM parameter f was positively correlated with the metabolic parameters SUVmean and SUVmax [ρ = 0.499 (p < 0.01) and ρ = 0.413 (p < 0.01), respectively]. There was a weak positive correlation between D* and SUVmean (ρ = 0.321, p = 0.041).
IVIM perfusion-related parameters, especially f, were correlated with F-FDG PET/CT metabolic parameters in patients with vertebral bone metastases. IVIM DW-MRI, used to evaluate metabolic activity, appears to have diagnostic potential for bone metastasis and may also have utility in monitoring the post-treatment response. Advances in knowledge: The use of IVIM for vertebral bone metastasis is demonstrated. f may be more suitable to reflect the metabolic activity and may facilitate another diagnostic potential for monitoring the posttreatment response.
探讨椎体骨转移患者体素内不相干运动(IVIM)扩散加权磁共振成像(DW MRI)参数与氟脱氧葡萄糖(FDG)正电子发射断层显像/X线计算机体层成像(PET/CT)代谢参数之间的关系。
本研究经机构审查委员会批准,回顾性纳入19例椎体骨转移患者。所有患者在治疗前均接受了IVIM DW-MRI和F-FDG PET/CT检查。使用11个b值(0、10、15、20、25、50、80、120、200、300和800 s/mm²)获取IVIM参数[分子扩散系数(D)、灌注分数(f)和灌注相关D(D*)]以及表观扩散系数。使用3.0标准化摄取值(SUV)的阈值计算F-FDG PET/CT得出的最大和平均标准化摄取值(分别为SUVmax和SUVmean)、代谢肿瘤体积和总病变糖酵解。通过Spearman相关分析评估参数之间的关联。
本研究共纳入19例患者和41个感兴趣区域。IVIM参数f与代谢参数SUVmean和SUVmax呈正相关[分别为ρ = 0.499(p < 0.01)和ρ = 0.413(p < 0.01)]。D*与SUVmean之间存在弱正相关(ρ = 0.321,p = 0.041)。
IVIM灌注相关参数,尤其是f,与椎体骨转移患者的F-FDG PET/CT代谢参数相关。用于评估代谢活性的IVIM DW-MRI似乎对骨转移具有诊断潜力,并且在监测治疗后反应方面可能也有用处。知识进展:证明了IVIM在椎体骨转移中的应用。f可能更适合反映代谢活性,并且可能有助于监测治疗后反应的另一种诊断潜力。